Biospring Partners
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Entrada Therapeutics
9Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Entrada Therapeutics | Biotech | Public | Apr 13, 2021 | $150.9M |
| Homology Medicines | Biotech | Acquired | Aug 10, 2017 | $106.6M |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#88
Co-investors#165
Co-investors
- 5AM VenturesVenture capital1 shared
- Atlas VentureVenture capital1 shared
- Foresite CapitalVenture capital1 shared
- Perceptive AdvisorsVenture capital1 shared
- RA CapitalVenture capital1 shared
- Sarepta TherapeuticsVenture capital1 shared
- Third Rock VenturesVenture capital1 shared
- Valence Life SciencesVenture capital1 shared
- XontogenyVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.